These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus. Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178 [TBL] [Abstract][Full Text] [Related]
10. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives. Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133 [TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
12. Serological evolution in women with positive antiphospholipid antibodies. Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307 [TBL] [Abstract][Full Text] [Related]
13. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome. Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447 [TBL] [Abstract][Full Text] [Related]
14. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. Goldstein R; Moulds JM; Smith CD; Sengar DP J Rheumatol; 1996 Jul; 23(7):1173-9. PubMed ID: 8823688 [TBL] [Abstract][Full Text] [Related]
15. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Peerschke EI; Yin W; Alpert DR; Roubey RA; Salmon JE; Ghebrehiwet B Lupus; 2009 May; 18(6):530-8. PubMed ID: 19395455 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG; Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399 [TBL] [Abstract][Full Text] [Related]
18. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus. Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069 [TBL] [Abstract][Full Text] [Related]
19. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. Giles I; Rahman A Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782 [TBL] [Abstract][Full Text] [Related]
20. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development]. Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]